APO Research
Talk to an analyst

APO RESEARCH · REPORT

Heparin

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

Selected research

Market Structure

Global Heparin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

9 January 2026199 pages

Choose your research edition.

Industry ResearchHeparin Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Heparin Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Heparin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Heparin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Heparin Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

Global Heparin key players include Hepalink, Bioibérica, Pfizer, King-friend Biochemical Pharmaceutical, Jiulong Biochemicals, etc. Global top five manufacturers hold a share about 55%. Europe is the largest market, with a share about 40%, followed by USA, with a share about 35 percent. In terms of product, Heparin Sodium Raw Material Drug is the largest segment, with a share about 96%. And in terms of application, the largest application is Low Molecular Weight Heparin Preparation, followed by Standard Heparin Preparation.

The report provides an overview of the global Heparin market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Heparin and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Heparin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Heparin market size, projected growth trends, production technologies, key applications, and end-use industries.

Heparin Segment by Company

Hepalink

Changshan Pharm

Qianhong Bio-pharma

Opocrin

Pfizer

Aspen Oss

King-friend Biochemical Pharmaceutical

Bioibérica

Dongcheng Biochemicals

Jiulong Biochemicals

Tiandong

Xinbai

Yino Pharma

Deebio

Heparin Segment by Type

Heparin Sodium Raw Material Drug

Heparin Calcium Raw Material Drug

Heparin Segment by Application

Low Molecular Weight Heparin Preparation

Standard Heparin Preparation

Heparin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Heparin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Heparin market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Heparin industry.

Chapter 3: Detailed analysis of Heparin market competition landscape. Including Heparin manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Heparin by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Heparin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Heparin Industry Trends Table 2. Heparin Industry Drivers Table 3. Heparin Industry Opportunities and Challenges Table 4. Heparin Industry Restraints Table 5. Global Heparin Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Heparin Production Value Share by Manufacturers (2021-2026) Table 7. Global Heparin Production by Manufacturers (B Units) & (2021-2026) Table 8. Global Heparin Production Market Share by Manufacturers Table 9. Global Heparin Average Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Heparin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Heparin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Heparin Manufacturers, Product Type & Application Table 13. Global Heparin Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Heparin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Heparin Sodium Raw Material Drug Table 17. Major Manufacturers of Heparin Calcium Raw Material Drug Table 18. Global Heparin Production by Type 2021 VS 2025 VS 2032 (B Units) Table 19. Global Heparin Production by Type (2021-2026) & (B Units) Table 20. Global Heparin Production by Type (2027-2032) & (B Units) Table 21. Global Heparin Production Market Share by Type (2021-2026) Table 22. Global Heparin Production Market Share by Type (2027-2032) Table 23. Global Heparin Production Value by Type 2021 VS 2025 VS 2032 (B Units) Table 24. Global Heparin Production Value by Type (2021-2026) & (B Units) Table 25. Global Heparin Production Value by Type (2027-2032) & (B Units) Table 26. Global Heparin Production Value Market Share by Type (2021-2026) Table 27. Global Heparin Production Value Market Share by Type (2027-2032) Table 28. Major Manufacturers of Low Molecular Weight Heparin Preparation Table 29. Major Manufacturers of Standard Heparin Preparation Table 30. Global Heparin Production by Application 2021 VS 2025 VS 2032 (B Units) Table 31. Global Heparin Production by Application (2021-2026) & (B Units) Table 32. Global Heparin Production by Application (2027-2032) & (B Units) Table 33. Global Heparin Production Market Share by Application (2021-2026) Table 34. Global Heparin Production Market Share by Application (2027-2032) Table 35. Global Heparin Production Value by Application 2021 VS 2025 VS 2032 (B Units) Table 36. Global Heparin Production Value by Application (2021-2026) & (B Units) Table 37. Global Heparin Production Value by Application (2027-2032) & (B Units) Table 38. Global Heparin Production Value Market Share by Application (2021-2026) Table 39. Global Heparin Production Value Market Share by Application (2027-2032) Table 40. Hepalink Company Information Table 41. Hepalink Business Overview Table 42. Hepalink Heparin Production (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 43. Hepalink Heparin Product Portfolio Table 44. Hepalink Recent Development Table 45. Changshan Pharm Company Information Table 46. Changshan Pharm Business Overview Table 47. Changshan Pharm Heparin Production (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 48. Changshan Pharm Heparin Product Portfolio Table 49. Changshan Pharm Recent Development Table 50. Qianhong Bio-pharma Company Information Table 51. Qianhong Bio-pharma Business Overview Table 52. Qianhong Bio-pharma Heparin Production (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 53. Qianhong Bio-pharma Heparin Product Portfolio Table 54. Qianhong Bio-pharma Recent Development Table 55. Opocrin Company Information Table 56. Opocrin Business Overview Table 57. Opocrin Heparin Production (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 58. Opocrin Heparin Product Portfolio Table 59. Opocrin Recent Development Table 60. Pfizer Company Information Table 61. Pfizer Business Overview Table 62. Pfizer Heparin Production (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 63. Pfizer Heparin Product Portfolio Table 64. Pfizer Recent Development Table 65. Aspen Oss Company Information Table 66. Aspen Oss Business Overview Table 67. Aspen Oss Heparin Production (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 68. Aspen Oss Heparin Product Portfolio Table 69. Aspen Oss Recent Development Table 70. King-friend Biochemical Pharmaceutical Company Information Table 71. King-friend Biochemical Pharmaceutical Business Overview Table 72. King-friend Biochemical Pharmaceutical Heparin Production (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 73. King-friend Biochemical Pharmaceutical Heparin Product Portfolio Table 74. King-friend Biochemical Pharmaceutical Recent Development Table 75. Bioibérica Company Information Table 76. Bioibérica Business Overview Table 77. Bioibérica Heparin Production (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 78. Bioibérica Heparin Product Portfolio Table 79. Bioibérica Recent Development Table 80. Dongcheng Biochemicals Company Information Table 81. Dongcheng Biochemicals Business Overview Table 82. Dongcheng Biochemicals Heparin Production (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 83. Dongcheng Biochemicals Heparin Product Portfolio Table 84. Dongcheng Biochemicals Recent Development Table 85. Jiulong Biochemicals Company Information Table 86. Jiulong Biochemicals Business Overview Table 87. Jiulong Biochemicals Heparin Production (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Jiulong Biochemicals Heparin Product Portfolio Table 89. Jiulong Biochemicals Recent Development Table 90. Tiandong Company Information Table 91. Tiandong Business Overview Table 92. Tiandong Heparin Production (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Tiandong Heparin Product Portfolio Table 94. Tiandong Recent Development Table 95. Xinbai Company Information Table 96. Xinbai Business Overview Table 97. Xinbai Heparin Production (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Xinbai Heparin Product Portfolio Table 99. Xinbai Recent Development Table 100. Yino Pharma Company Information Table 101. Yino Pharma Business Overview Table 102. Yino Pharma Heparin Production (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Yino Pharma Heparin Product Portfolio Table 104. Yino Pharma Recent Development Table 105. Deebio Company Information Table 106. Deebio Business Overview Table 107. Deebio Heparin Production (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. Deebio Heparin Product Portfolio Table 109. Deebio Recent Development Table 110. Global Heparin Production by Region: 2021 VS 2025 VS 2032 (B Units) Table 111. Global Heparin Production by Region (2021-2026) & (B Units) Table 112. Global Heparin Production Market Share by Region (2021-2026) Table 113. Global Heparin Production Forecast by Region (2027-2032) & (B Units) Table 114. Global Heparin Production Market Share Forecast by Region (2027-2032) Table 115. Global Heparin Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 116. Global Heparin Production Value by Region (2021-2026) & (US$ Million) Table 117. Global Heparin Production Value Share by Region (2021-2026) Table 118. Global Heparin Production Value by Region (2027-2032) & (US$ Million) Table 119. Global Heparin Production Value Share by Region: (2027-2032) & (US$ Million) Table 120. Global Heparin Market Average Price (USD/Unit) by Region (2021-2026) Table 121. Global Heparin Market Average Price (USD/Unit) by Region (2027-2032) Table 122. Global Heparin Consumption by Region: 2021 VS 2025 VS 2032 (B Units) Table 123. Global Heparin Consumption by Region (2021-2026) & (B Units) Table 124. Global Heparin Consumption Market Share by Region (2021-2026) Table 125. Global Heparin Consumption Forecasted by Region (2027-2032) & (B Units) Table 126. Global Heparin Consumption Forecasted Market Share by Region (2027-2032) Table 127. North America Heparin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (B Units) Table 128. North America Heparin Consumption by Country (2021-2026) & (B Units) Table 129. North America Heparin Consumption by Country (2027-2032) & (B Units) Table 130. Europe Heparin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (B Units) Table 131. Europe Heparin Consumption by Country (2021-2026) & (B Units) Table 132. Europe Heparin Consumption by Country (2027-2032) & (B Units) Table 133. Asia Pacific Heparin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (B Units) Table 134. Asia Pacific Heparin Consumption by Country (2021-2026) & (B Units) Table 135. Asia Pacific Heparin Consumption by Country (2027-2032) & (B Units) Table 136. South America Heparin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (B Units) Table 137. South America Heparin Consumption by Country (2021-2026) & (B Units) Table 138. South America Heparin Consumption by Country (2027-2032) & (B Units) Table 139. Middle East & Africa Heparin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (B Units) Table 140. Middle East & Africa Heparin Consumption by Country (2021-2026) & (B Units) Table 141. Middle East & Africa Heparin Consumption by Country (2027-2032) & (B Units) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Heparin Distributors List Table 145. Heparin Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Heparin Product Image Figure 2. Global Heparin Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Heparin Production Value (2021-2032) & (US$ Million) Figure 4. Global Heparin Production Capacity (2021-2032) & (B Units) Figure 5. Global Heparin Production (2021-2032) & (B Units) Figure 6. Global Heparin Average Price (USD/Unit) & (2021-2032) Figure 7. Global Top 5 and 10 Heparin Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Heparin Sodium Raw Material Drug Image Figure 10. Heparin Calcium Raw Material Drug Image Figure 11. Global Heparin Production by Type (2021 VS 2025 VS 2032) & (B Units) Figure 12. Global Heparin Production Market Share 2021 VS 2025 VS 2032 Figure 13. Global Heparin Production Market Share by Type (2021-2032) Figure 14. Global Heparin Production Value by Type (2021 VS 2025 VS 2032) & (B Units) Figure 15. Global Heparin Production Value Share 2021 VS 2025 VS 2032 Figure 16. Global Heparin Production Value Share by Type (2021-2032) Figure 17. Low Molecular Weight Heparin Preparation Image Figure 18. Standard Heparin Preparation Image Figure 19. Global Heparin Production by Application (2021 VS 2025 VS 2032) & (B Units) Figure 20. Global Heparin Production Market Share 2021 VS 2025 VS 2032 Figure 21. Global Heparin Production Market Share by Application (2021-2032) Figure 22. Global Heparin Production Value by Application (2021 VS 2025 VS 2032) & (B Units) Figure 23. Global Heparin Production Value Share 2021 VS 2025 VS 2032 Figure 24. Global Heparin Production Value Share by Application (2021-2032) Figure 25. Global Heparin Production by Region: 2021 VS 2025 VS 2032 (B Units) Figure 26. Global Heparin Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Heparin Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Heparin Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Heparin Production Value (2021-2032) & (US$ Million) Figure 30. Europe Heparin Production Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific Heparin Production Value (2021-2032) & (US$ Million) Figure 32. South America Heparin Production Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Heparin Production Value (2021-2032) & (US$ Million) Figure 34. North America Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 35. North America Heparin Consumption Market Share by Country (2021-2032) Figure 36. U.S. Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 37. Canada Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 38. Mexico Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 39. Europe Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 40. Europe Heparin Consumption Market Share by Country (2021-2032) Figure 41. Germany Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 42. France Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 43. U.K. Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 44. Italy Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 45. Netherlands Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 46. Asia Pacific Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 47. Asia Pacific Heparin Consumption Market Share by Country (2021-2032) Figure 48. China Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 49. Japan Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 50. South Korea Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 51. Southeast Asia Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 52. India Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 53. Australia Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 54. South America Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 55. South America Heparin Consumption Market Share by Country (2021-2032) Figure 56. Brazil Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 57. Argentina Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 58. Chile Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 59. Middle East & Africa Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 60. Middle East & Africa Heparin Consumption Market Share by Country (2021-2032) Figure 61. Egypt Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 62. South Africa Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 63. Israel Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 64. Türkiye Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 65. GCC Countries Heparin Consumption and Growth Rate (2021-2032) & (B Units) Figure 66. Heparin Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Heparin Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Heparin Sodium Raw Material Drug
  • Heparin Calcium Raw Material Drug
Applications
  • Low Molecular Weight Heparin Preparation
  • Standard Heparin Preparation
Companies covered
  • Hepalink
  • Changshan Pharm
  • Qianhong Bio-pharma
  • Opocrin
  • Pfizer
  • Aspen Oss
  • King-friend Biochemical Pharmaceutical
  • Bioibérica
  • Dongcheng Biochemicals
  • Jiulong Biochemicals
  • Tiandong
  • Xinbai
  • Yino Pharma
  • Deebio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Heparin Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Heparin Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Heparin Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Heparin Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Heparin Market Dynamics
  1. 2.1 Heparin Industry Trends
  2. 2.2 Heparin Industry Drivers
  3. 2.3 Heparin Industry Opportunities and Challenges
  4. 2.4 Heparin Industry Restraints
3 Heparin Market by Manufacturers
  1. 3.1 Global Heparin Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Heparin Production by Manufacturers (2021-2026)
  3. 3.3 Global Heparin Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Heparin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Heparin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Heparin Manufacturers, Product Type & Application
  7. 3.7 Global Heparin Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Heparin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Heparin Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Heparin Tier 1, Tier 2, and Tier 3
4 Heparin Market by Type
  1. 4.1 Heparin Type Introduction
  2. 4.1.1 Heparin Sodium Raw Material Drug
  3. 4.1.2 Heparin Calcium Raw Material Drug
  4. 4.2 Global Heparin Production by Type
  5. 4.2.1 Global Heparin Production by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Heparin Production by Type (2021-2032)
  7. 4.2.3 Global Heparin Production Market Share by Type (2021-2032)
  8. 4.3 Global Heparin Production Value by Type
  9. 4.3.1 Global Heparin Production Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Heparin Production Value by Type (2021-2032)
  11. 4.3.3 Global Heparin Production Value Market Share by Type (2021-2032)
5 Heparin Market by Application
  1. 5.1 Heparin Application Introduction
  2. 5.1.1 Low Molecular Weight Heparin Preparation
  3. 5.1.2 Standard Heparin Preparation
  4. 5.2 Global Heparin Production by Application
  5. 5.2.1 Global Heparin Production by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Heparin Production by Application (2021-2032)
  7. 5.2.3 Global Heparin Production Market Share by Application (2021-2032)
  8. 5.3 Global Heparin Production Value by Application
  9. 5.3.1 Global Heparin Production Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Heparin Production Value by Application (2021-2032)
  11. 5.3.3 Global Heparin Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Hepalink
  2. 6.1.1 Hepalink Company Information
  3. 6.1.2 Hepalink Business Overview
  4. 6.1.3 Hepalink Heparin Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 Hepalink Heparin Product Portfolio
  6. 6.1.5 Hepalink Recent Developments
  7. 6.2 Changshan Pharm
  8. 6.2.1 Changshan Pharm Company Information
  9. 6.2.2 Changshan Pharm Business Overview
  10. 6.2.3 Changshan Pharm Heparin Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Changshan Pharm Heparin Product Portfolio
  12. 6.2.5 Changshan Pharm Recent Developments
  13. 6.3 Qianhong Bio-pharma
  14. 6.3.1 Qianhong Bio-pharma Company Information
  15. 6.3.2 Qianhong Bio-pharma Business Overview
  16. 6.3.3 Qianhong Bio-pharma Heparin Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Qianhong Bio-pharma Heparin Product Portfolio
  18. 6.3.5 Qianhong Bio-pharma Recent Developments
  19. 6.4 Opocrin
  20. 6.4.1 Opocrin Company Information
  21. 6.4.2 Opocrin Business Overview
  22. 6.4.3 Opocrin Heparin Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 Opocrin Heparin Product Portfolio
  24. 6.4.5 Opocrin Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Heparin Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Heparin Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Aspen Oss
  32. 6.6.1 Aspen Oss Company Information
  33. 6.6.2 Aspen Oss Business Overview
  34. 6.6.3 Aspen Oss Heparin Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Aspen Oss Heparin Product Portfolio
  36. 6.6.5 Aspen Oss Recent Developments
  37. 6.7 King-friend Biochemical Pharmaceutical
  38. 6.7.1 King-friend Biochemical Pharmaceutical Company Information
  39. 6.7.2 King-friend Biochemical Pharmaceutical Business Overview
  40. 6.7.3 King-friend Biochemical Pharmaceutical Heparin Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 King-friend Biochemical Pharmaceutical Heparin Product Portfolio
  42. 6.7.5 King-friend Biochemical Pharmaceutical Recent Developments
  43. 6.8 Bioibérica
  44. 6.8.1 Bioibérica Company Information
  45. 6.8.2 Bioibérica Business Overview
  46. 6.8.3 Bioibérica Heparin Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 Bioibérica Heparin Product Portfolio
  48. 6.8.5 Bioibérica Recent Developments
  49. 6.9 Dongcheng Biochemicals
  50. 6.9.1 Dongcheng Biochemicals Company Information
  51. 6.9.2 Dongcheng Biochemicals Business Overview
  52. 6.9.3 Dongcheng Biochemicals Heparin Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 Dongcheng Biochemicals Heparin Product Portfolio
  54. 6.9.5 Dongcheng Biochemicals Recent Developments
  55. 6.10 Jiulong Biochemicals
  56. 6.10.1 Jiulong Biochemicals Company Information
  57. 6.10.2 Jiulong Biochemicals Business Overview
  58. 6.10.3 Jiulong Biochemicals Heparin Production, Value and Gross Margin (2021-2026)
  59. 6.10.4 Jiulong Biochemicals Heparin Product Portfolio
  60. 6.10.5 Jiulong Biochemicals Recent Developments
  61. 6.11 Tiandong
  62. 6.11.1 Tiandong Company Information
  63. 6.11.2 Tiandong Business Overview
  64. 6.11.3 Tiandong Heparin Production, Value and Gross Margin (2021-2026)
  65. 6.11.4 Tiandong Heparin Product Portfolio
  66. 6.11.5 Tiandong Recent Developments
  67. 6.12 Xinbai
  68. 6.12.1 Xinbai Company Information
  69. 6.12.2 Xinbai Business Overview
  70. 6.12.3 Xinbai Heparin Production, Value and Gross Margin (2021-2026)
  71. 6.12.4 Xinbai Heparin Product Portfolio
  72. 6.12.5 Xinbai Recent Developments
  73. 6.13 Yino Pharma
  74. 6.13.1 Yino Pharma Company Information
  75. 6.13.2 Yino Pharma Business Overview
  76. 6.13.3 Yino Pharma Heparin Production, Value and Gross Margin (2021-2026)
  77. 6.13.4 Yino Pharma Heparin Product Portfolio
  78. 6.13.5 Yino Pharma Recent Developments
  79. 6.14 Deebio
  80. 6.14.1 Deebio Company Information
  81. 6.14.2 Deebio Business Overview
  82. 6.14.3 Deebio Heparin Production, Value and Gross Margin (2021-2026)
  83. 6.14.4 Deebio Heparin Product Portfolio
  84. 6.14.5 Deebio Recent Developments
7 Global Heparin Production by Region
  1. 7.1 Global Heparin Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Heparin Production by Region (2021-2032)
  3. 7.2.1 Global Heparin Production by Region (2021-2026)
  4. 7.2.2 Global Heparin Production Forecast by Region (2027-2032)
  5. 7.3 Global Heparin Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Heparin Production Value by Region (2021-2032)
  7. 7.4.1 Global Heparin Production Value by Region (2021-2026)
  8. 7.4.2 Global Heparin Production Value by Region (2027-2032)
  9. 7.5 Global Heparin Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Heparin Production Value (2021-2032)
  12. 7.6.2 Europe Heparin Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Heparin Production Value (2021-2032)
  14. 7.6.4 South America Heparin Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Heparin Production Value (2021-2032)
8 Global Heparin Consumption by Region
  1. 8.1 Global Heparin Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Heparin Consumption by Region (2021-2032)
  3. 8.2.1 Global Heparin Consumption by Region (2021-2026)
  4. 8.2.2 Global Heparin Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Heparin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Heparin Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Heparin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Heparin Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Heparin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Heparin Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Heparin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Heparin Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Heparin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Heparin Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Heparin Value Chain Analysis
  2. 9.1.1 Heparin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Heparin Production Mode & Process
  6. 9.2 Heparin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Heparin Distributors
  9. 9.2.3 Heparin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst